XML 22 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income $ 6,828,000,000 $ 1,588,000,000 $ 4,849,000,000
Less: Net income attributable to the noncontrolling interest 63,000,000 43,000,000 37,000,000
Net income attributable to Honeywell 6,765,000,000 1,545,000,000 4,812,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:      
Depreciation 721,000,000 717,000,000 726,000,000
Amortization 395,000,000 398,000,000 304,000,000
{Gain) loss on sale of non-strategic businesses and assets 0 7,000,000 (178,000,000)
Repositioning and other charges 1,091,000,000 973,000,000 690,000,000
Net payments for repositioning and other charges (652,000,000) (628,000,000) (625,000,000)
Pension and other postretirement (income) expense (987,000,000) (647,000,000) (360,000,000)
Pension and other postretirement benefit payments (80,000,000) (106,000,000) (143,000,000)
Stock compensation expense 175,000,000 176,000,000 184,000,000
Deferred income taxes (586,000,000) 2,452,000,000 78,000,000
Other (694,000,000) 1,642,000,000 194,000,000
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:      
Accounts receivable (236,000,000) (682,000,000) (547,000,000)
Inventories (503,000,000) (259,000,000) (18,000,000)
Other current assets 218,000,000 (568,000,000) (106,000,000)
Accounts payable 733,000,000 924,000,000 254,000,000
Accrued liabilities 74,000,000 22,000,000 233,000,000
Net cash provided by operating activities 6,434,000,000 5,966,000,000 5,498,000,000
Cash flows from investing activities:      
Expenditures for property, plant and equipment (828,000,000) (1,031,000,000) (1,095,000,000)
Proceeds from disposals of property, plant and equipment 15,000,000 86,000,000 21,000,000
Increase in investments (4,059,000,000) (6,743,000,000) (3,954,000,000)
Decrease in investments 6,032,000,000 4,414,000,000 3,681,000,000
Cash paid for acquisitions, net of cash acquired (535,000,000) (82,000,000) (2,573,000,000)
Proceeds from sales of businesses, net of fees paid 0 0 296,000,000
Other 402,000,000 (218,000,000) 282,000,000
Net cash provided by (used for) investing activities 1,027,000,000 (3,574,000,000) (3,342,000,000)
Cash flows from financing activities:      
Proceeds from issuance of commercial paper and other short-term borrowings 23,891,000,000 13,701,000,000 18,997,000,000
Payments of commercial paper and other short-term borrowings (24,095,000,000) (13,532,000,000) (21,461,000,000)
Proceeds from issuance of common stock 267,000,000 520,000,000 409,000,000
Proceeds from issuance of long-term debt 27,000,000 1,238,000,000 9,245,000,000
Payments of long-term debt (1,330,000,000) (292,000,000) (2,839,000,000)
Repurchases of common stock (4,000,000,000) (2,889,000,000) (2,079,000,000)
Cash dividends paid (2,272,000,000) (2,119,000,000) (1,915,000,000)
Payments to purchase the noncontrolling interest 0 0 (238,000,000)
Pre-separation funding 2,801,000,000 0 269,000,000
Pre-spin borrowing 0 0 38,000,000
Spin-off cash (179,000,000) 0 (38,000,000)
Other (142,000,000) (143,000,000) (42,000,000)
Net cash (used for) provided by financing activities (5,032,000,000) (3,516,000,000) 346,000,000
Effect of foreign exchange rate changes on cash and cash equivalents (201,000,000) 340,000,000 (114,000,000)
Net increase (decrease) in cash and cash equivalents 2,228,000,000 (784,000,000) 2,388,000,000
Cash and cash equivalents at beginning of period 7,059,000,000 7,843,000,000 5,455,000,000
Cash and cash equivalents at end of period $ 9,287,000,000 $ 7,059,000,000 $ 7,843,000,000